Month: September 2026

Angi is part of a select group of brands testing a new conversational advertising experience in ChatGPT

DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) — Angi (formerly Angie’s List) (NASDAQ: ANGI), a leading digital home services marketplace, today announced it is participating in OpenAI’s Sponsored Agent pilot. The pilot supports Angi’s expansion into emerging AI-powered advertising surfaces, creating a new way to reach homeowners and connect them with skilled local pros.

In this pilot, an Angi-branded sponsored agent may appear in relevant ChatGPT conversations regarding home services. Homeowners will be able to continue the conversation with the Angi agent to share more information about their project and when the job calls for help from a pro, enter Angi’s service request flow to connect with skilled local pros.

“Our AI-first strategy is simple: make it easier for homeowners to connect with and hire the right pro for their project,” said Angie Hicks, co-founder of Angi. “With OpenAI’s Sponsored Agent pilot, homeowners can go directly from discussing a home project in ChatGPT to connecting with a skilled local pro who can help.”

Home services are a high-consideration category, with homeowners often spending significant time researching a project’s scope, urgency and complexity before deciding whether to hire a professional.

The advertising pilot builds on Angi’s existing app in ChatGPT earlier this year, which helps homeowners move from asking a home improvement question to hiring a pro through an AI-guided experience. Unlike the Angi app, which homeowners choose to add in ChatGPT, the Angi-sponsored agent may appear as a clearly labeled sponsored experience within relevant conversations that homeowners can choose to chat with.

To learn more about Angi, visit www.angi.com.

About Angi Inc.
Angi (NASDAQ: ANGI) helps homeowners get home projects done well and helps home service professionals grow their businesses. Founded in 1995, Angi connects homeowners with skilled local professionals, from plumbers and electricians to remodelers and landscapers, and provides tools for researching costs, planning projects and hiring with confidence.Homeowners have turned to Angi, and our vast network of skilled home pros, for help with more than 300 million projects.

Contact Information
Angi Corporate Communications
Jennifer Myers
(303) 963-8352

ASUS validates its leadership in design and innovation with a Bronze Award, plus finalist places for ExpertBook Ultra, ROG XBOX Ally Series, and ROG Zephyrus Duo

KEY POINTS

• The IDEA awards validate the user-centric ASUS approach and design-thinking philosophy that continuously deliver cutting-edge products
• Zenbook DUO awarded Bronze in the Consumer Technology category for redefining dual-screen productivity with its innovative design
• ExpertBook Ultra, ROG XBOX Ally Series, and Zephyrus Duo named finalists for innovation in the Mobility & Gaming category

TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE) — ASUS today announced that the Zenbook DUO (2026) (UX8407) laptop won a Bronze Award in the Consumer Technology category at the International Design Excellence Awards (IDEA) 2026. Additionally, three other ASUS products were named as finalists. This distinction reflects the company’s commitment to delivering groundbreaking technologies that enhance users’ lives.

Zenbook DUO secured the Bronze Award for redefining dual-screen productivity with cutting-edge design, while the ExpertBook Ultra, Republic of Gamers (ROG) XBOX Ally Series, and ROG Zephyrus Duo were shortlisted for innovation in the Mobility & Gaming category.

“We are delighted to receive the IDEA Bronze Award, which highlights the team’s pursuit of design excellence,” said Mitch Yang, ASUS Chief Design Officer. “We always strive to create innovative, user-centric technologies that push boundaries and deliver exceptional experiences for users, with our Design Thinking philosophy at the center of every product.”

Zenbook DUO – elegant innovation

The innovation of Zenbook DUO (2026) (UX8407) lies in its seamless dual-screen integration, achieving unprecedented visual continuity in a slender form factor. The detachable keyboard with ‘invisible connectivity’ and the integrated kickstand offer ergonomic flexibility. The proprietary ASUS Ceraluminum^™ material provides structural integrity and a unique aesthetic, while the vertical dual-screen mode promotes better posture and redefines mobile productivity.

Zenbook DUO features dual 14-inch 3K OLED 144Hz displays with a minimal 7.66mm gap, integrated via a precision hinge. It includes a detachable Bluetooth^® keyboard with a low-friction surface and retractable charging, an integrated kickstand, and is powered by an Intel^® Core^™ Ultra Series 3 processor. ASUS ScreenXpert software enhances its dual-screen functionality with advanced gestures.

Three ASUS products named as finalists

Among the IDEA 2026 finalists were the ExpertBook Ultra business laptop, the ROG Zephyrus Duo (2026) gaming laptop, and the ROG XBOX Ally series of gaming handhelds. ExpertBook Ultra enables uninterrupted focus through its powerful, silent operation and long-term reliability against daily wear. Dongle-free connectivity and a clutter-free workspace ensure seamless productivity. Enhanced comfort comes from reduced glare, which minimizes sensory fatigue and makes extended use more pleasant.

The ROG Zephyrus Duo delivers genuine dual-monitor productivity anywhere, streamlining complex workflows for gaming, editing, or AI tasks with an expansive digital canvas. Its adaptive workflows, offering five usage modes, cater to diverse scenarios, while the detachable keyboard and consolidated workspace provide ergonomic flexibility and a powerful, portable solution.

The ROG XBOX Ally series’ ergonomic design and optimized weight ensure superior comfort and reduce fatigue for users. It lets users experience faster, smoother, and more immersive desktop-class PC gaming anywhere, thanks to a streamlined OS, optimized resource allocation, and precise controls, all within a sustainable design that minimizes environmental impact.

About IDEA

IDEA is organized by the Industrial Designers Society of America (IDSA). The 46th iteration of the award winners was announced on August 27, 2026, and it is one of the longest-running and most prestigious design award programs. IDEA winners are determined through blind evaluation by a jury of experts who assess thousands of entries based on design innovation, benefits to users, clients, and society, and appropriate aesthetics. Further details can be found at: https://www.idsa.org/IDEA

Press Contacts

Redoine Taoussi

Senior Public Relations Manager

Redoine_Taoussi@asus.com

Notes to Editors

ASUS Zenbook DUO (UX8407): https://www.asus.com/ca-en/laptops/for-home/zenbook/asus-zenbook-duo-ux8407/

ASUS ExpertBook Ultra: https://www.asus.com/ca-en/laptops/for-work/expertbook/asus-expertbook-ultra/

ROG Zephyrus Duo: https://rog.asus.com/ca-en/laptops/rog-zephyrus/rog-zephyrus-duo-2026/

ROG XBOX Ally Series: https://rog.asus.com/ca-en/gaming-handhelds/rog-ally-series/

IDEA Awards (IDSA): https://www.idsa.org/IDEA

ASUS Homepage: https://www.asus.com/ca-en/

ASUS AI PCs: https://www.asus.com/ca-en/content/asus-ai-pc/

ASUS Pressroom: http://press.asus.com

ASUS Canada Facebook: https://www.facebook.com/asuscanada/

ASUS Canada Instagram: https://www.instagram.com/asus_ca

ASUS Canada YouTube: https://ca.asus.click/youtube

ASUS Global X (Twitter): https://www.x.com/asus

About ASUS

ASUS (2357.TW) is an innovative technology leader delivering the world’s most comprehensive AI solutions across Infrastructure, Physical AI, AI PC/Devices, and Engineering the AI Advantage. Guided by its “Ubiquitous AI. Incredible Possibilities.” strategy, ASUS is bringing enterprise-to-edge AI to life. The ASUS portfolio also includes the ROG and ProArt sub-brands, which serve gamers and creators worldwide.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1dcdfbb2-6af2-4adb-bb7d-eca94c73f80e

HOMEWOOD, Ill., Sept. 16, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) Police officers along with other CN spokespeople will be available to members of the media during See Tracks? Think Train® Week from September 21-25, 2026. This annual public awareness campaign highlights the importance of safe behaviours near rail crossings and the danger of trespassing on railway property.

Uniformed CN Police officers and CN spokespeople will be available for interviews across CN’s network in the United States and will take part in community events throughout the week. Media outlets can contact CN’s media relations team to schedule phone, virtual or in-person (where possible) interviews as well as requests visuals to support broadcast, print, and online coverage.

Why Rail Safety Matters
Every year, preventable accidents occur at rail crossings and along railway property. CN’s message is simple: Safety is a shared responsibility. By working together with schools, communities, and media partners, CN aims to reduce incidents and save lives.

See Tracks? Think Train Activities
CN is proud to partner with Operation Lifesaver Inc. and local authorities across North America to deliver a range of online and in-person activities during See Tracks? Think Train® Week. These initiatives promote safe practices, raise awareness about rail crossing safety, and highlight the risks of trespassing on railway property. CN continues to invest in rail safety and invites all communities across its network to participate in See Tracks? Think Train® Week activities.

About CN Police
Every year, CN Police Services respond to hundreds of events across the eight Canadian provinces and 16 U.S. states within our network. In addition to protecting CN property, CNPS officers deliver rail safety presentations to schools, trucking agencies, bus operators and community organizations. By rolling out strategic educational initiatives and conducting targeted operations, CNPS aims to promote safe behaviors and increase awareness of rail safety. CNPS is committed to making CN the safest railroad in North America.

For more information or to schedule an interview with a CN Police Officer, please contact:

US
Canada

MONTREAL, Sept. 16, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) Police officers along with other CN spokespeople will be available to members of the media during Rail Safety Week from September 21-25, 2026. This annual public awareness campaign highlights the importance of safe behaviours near railway crossings and the danger of trespassing on railway property.

Uniformed CN Police officers and CN spokespeople will be available for interviews across Canada and will take part in community events throughout the week. Media outlets can contact CN’s media relations team to schedule phone, virtual or in-person (where possible) interviews as well as requests visuals to support broadcast, print, and online coverage.

Why Rail Safety Matters
Every year, preventable accidents occur at rail crossings and along railway property. CN’s message is simple: Safety is a shared responsibility. By working together with schools, communities, and media partners, CN aims to reduce incidents and save lives.

Rail Safety Week Activities
CN is proud to partner with Operation Lifesaver and local authorities across North America to deliver a range of online and in-person activities during Rail Safety Week. These initiatives promote safe practices, raise awareness about rail crossing safety, and highlight the risks of trespassing on railway property. CN continues to invest in rail safety and invites all communities across its network to participate in Rail Safety Week activities.

About CN Police
Every year, CN Police Services respond to hundreds of events across the eight Canadian provinces and 16 U.S. states within our network. In addition to protecting CN property, CNPS officers deliver rail safety presentations to schools, trucking agencies, bus operators and community organizations. By rolling out strategic educational initiatives and conducting targeted operations, CNPS aims to promote safe behaviours and increase awareness of rail safety. CNPS is committed to making CN the safest railroad in North America.

For more information or to schedule an interview with a CN Police Officer, please contact:

Alberta
Atlantic
British Columbia
Manitoba
Ontario
Quebec
Saskatchewan
Canada

KRTL outlines how expanded regulatory leadership expects to support its developing South American API, botanical, controlled substance, and pharmaceutical strategy

Lakewood, CO, Sept. 16, 2026 (GLOBE NEWSWIRE) — KRTL Holding Group Inc. (OTC: KRTL) (“KRTL” or the “Company”) today outlined how KRTL Biotech Inc. intends to apply its expanded regulatory leadership to the Company’s developing South American pharmaceutical API, controlled-substance, botanical-drug, research, and regulatory-services strategy.

Justin Abril, KRTL Biotech’s President-Designate and Strategic Regulatory & API Consultant, https://krtlbiotech.com/team/justin-abril, brings more than a decade of experience in federal controlled-substance compliance, Schedule I manufacturing, DEA regulatory affairs, and pharmaceutical quality systems. His experience is expected to support KRTL’s developing API, controlled-substance, botanical-drug, and regulatory initiatives.

KRTL believes that developing international pharmaceutical supply relationships requires more than identifying compounds, suppliers, laboratories, or manufacturers. Prospective opportunities must be evaluated against regulatory, quality, security, documentation, analytical, manufacturing, import, and downstream-development requirements before they can be considered for a U.S. pharmaceutical pathway.

Developing a South American API Qualification Pathway

KRTL is evaluating and developing prospective South American relationships involving pharmaceutical APIs, botanical-derived materials, laboratories, technical capabilities, and manufacturing partners. These capabilities are not represented as currently qualified, licensed, or commercially API-ready for any U.S. program. KRTL intends to advance selected opportunities through technical, quality, regulatory, contractual, and commercial diligence before they are considered for U.S. pharmaceutical development or importation.

Abril will help KRTL build the regulatory and qualification framework used to evaluate prospective facilities, API manufacturers, laboratories, botanical sources, research organizations, and technical partners.

• API and CMC documentation and development readiness.
• cGMP manufacturing and pharmaceutical quality systems.
• Analytical testing, specifications, and quality controls.
• Supplier, facility, and partner qualification.
• Supply-chain integrity, traceability, and change-control expectations.
• U.S. import eligibility and appropriate importer pathways.
• DEA registration scope, controlled-substance drug codes, quotas, and import/export authority where applicable.
• Controlled-substance security, storage, recordkeeping, and inventory accountability.
• Applicable FDA, state, institutional, and foreign-country requirements.
• Qualified U.S. research, manufacturing, development, and commercialization partners.
“As we develop prospective relationships in South America, our objective is to determine which opportunities can realistically progress into compliant U.S. pharmaceutical programs,” said Cesar Herrera, Chief Executive Officer of KRTL Biotech Inc. “Justin will help us establish the regulatory, quality, and partner-qualification framework needed to evaluate those opportunities systematically.”

Supporting KRTL’s Coca-Derived Pharmaceutical and API Strategy

KRTL has developed two coca-derived extract platforms, Rayel and Periko. Company records include a TTB formula approval record for Rayel Decocainized Natural Coca Extract, providing an existing regulatory foundation for its applicable beverage-facing use. Together, the two extracts provide KRTL with multiple pathways to evaluate across commercial, analytical, formulation, API, and pharmaceutical applications.

Abril’s experience in Schedule I manufacturing, controlled-substance compliance, pharmaceutical quality systems, DEA regulatory affairs, and regulated supply chains is expected to help KRTL advance these existing assets through the appropriate regulatory and development pathways. His role is expected to include supporting qualification, quality and documentation requirements, CMC readiness, import/export planning, and identification of qualified operating and development partners.

Any coca-derived pharmaceutical or API program would remain subject to applicable DEA, FDA, state, foreign-government, customs, quality, security, and institutional requirements.

Broader Controlled-Substance and Psychedelic Research Opportunities

KRTL also intends to evaluate opportunities involving controlled botanical-drug development, pharmaceutical APIs, Schedule I research, psychedelic compounds, formulation development, analytical testing, CMC development, and institutional research collaborations.

Potential collaborators may include appropriately authorized universities, researchers, laboratories, manufacturers, CROs, clinical sites, importers/exporters, and other qualified institutions. Any such work would remain subject to the activity-specific legal and regulatory requirements applicable to the responsible operating entities.

Extending Regulatory Expertise into Third-Party Consulting Services

KRTL also expects the regulatory infrastructure being developed internally, to support the evaluation and qualification of suppliers, manufacturers, laboratories and collaborators, and, where appropriate, to support qualified third parties engaged in similar categories of pharmaceutical and controlled-substance activity that KRTL is developing. The contemplated services may include registration-readiness, facility and security planning, SOP and recordkeeping support, quota and ARCOS compliance support where applicable, import/export pathway planning, inspection readiness, supplier and facility qualification, and related cGMP and quality-system consulting.

This capability is intended to complement KRTL’s internal development programs by applying the same regulatory, quality, security, and compliance disciplines to third-party engagements. KRTL Biotech would provide advisory, readiness, documentation, and strategic support; responsibility for applications, regulated activities, and government authorizations would remain with the applicable applicant or authorized operating entity.

From Opportunity Identification to Regulatory Qualification

KRTL views Abril’s addition as part of a broader effort to strengthen the regulatory, quality, technical, institutional, manufacturing, and advisory framework used to evaluate pharmaceutical programs and support qualified third-party engagements. The Company intends to develop a repeatable diligence and qualification process that can be applied across multiple API, botanical, controlled substance, research, and consulting initiatives.

“The objective is to understand the pathway before significant resources are committed,” Herrera said. “That means identifying the regulatory requirements, qualifying the right partners, understanding the facility and quality gaps, and determining what is needed to move a viable opportunity into a legitimate development program.”

Neither Abril’s appointment nor KRTL’s current development activities should be interpreted as evidence that any South American facility, controlled-substance program, API, pharmaceutical product, DEA registration, quota, import authorization, FDA submission, or research program has received regulatory approval or is commercially operational unless specifically disclosed by the Company.

About KRTL Biotech Inc.

KRTL Biotech Inc. is a wholly owned subsidiary of KRTL Holding Group Inc. focused on pharmaceutical, biotechnology, active pharmaceutical ingredient (API), botanical, regulatory, research, and commercialization opportunities in the United States and international markets. KRTL Biotech maintains federal registrations and entity identifiers with the U.S. Food and Drug Administration and SAM.gov, including SAM.gov UEI ULPJWZWBM9L5 and CAGE Code 109P9. These registrations and identifiers support the Company’s developing pharmaceutical, regulatory, research, government-contracting, and commercialization activities and do not, by themselves, constitute FDA approval of any specific product, DEA authority, or authorization for any specific controlled-substance activity.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements regarding anticipated executive roles, pharmaceutical and API strategies, controlled substance and psychedelic research initiatives, regulatory activities, partner qualification, research collaborations, manufacturing relationships, import/export pathways, financing, commercialization, and future operations. Forward-looking statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. There can be no assurance that contemplated regulatory registrations, permits, quotas, research approvals, import/export authorizations, manufacturing arrangements, institutional collaborations, pharmaceutical development programs, financing, or commercialization activities will be obtained or completed. Neither KRTL Holding Group Inc. nor KRTL Biotech Inc. represents that any compound, API, pharmaceutical product, manufacturing facility, research program, controlled-substance activity, DEA registration, quota, drug code, FDA submission, import authorization, or other regulated activity discussed herein has received regulatory approval unless specifically stated otherwise.

CONTACT: www.krtlholding.com
info@krtlholding.com

Contact: 855-KRTL-HLD


www.krtlbiotech.com
info@krtlbiotech.com

www.krtl-icc.com
info@krtl-icc.com

The agreement strengthens India’s pioneering efforts to develop Bio-IBA as a renewable blending solution for decarbonizing one of the world’s largest diesel markets.

ENGLEWOOD, Colo and PUNE, India, Sept. 16, 2026 (GLOBE NEWSWIRE) — Praj Industries and Gevo, Inc. (NASDAQ: GEVO) today announced the signing of a Development & Commercialization Agreement for Bio-Isobutanol (Bio-IBA) technology in India, reinforcing their long-standing association to advance sustainable low-carbon fuel solutions.

Under the agreement, Praj will lead the commercialization of Bio-IBA technology in India, with exclusive rights to deploy the technology in the country. The partnership will focus on developing commercial opportunities for Bio-IBA, with a primary emphasis on diesel blending applications that have the potential to reduce the carbon intensity of one of the world’s most widely used transportation and industrial fuels.

The agreement builds upon more than a decade of association between the two companies to adapt, develop and advance Bio-IBA technology for Indian feedstocks and market requirements. Praj’s deep understanding of India’s sugar- and starch-based feedstocks, its expertise in engineering, project execution, scale-up and market development, combined with Gevo’s Bio-IBA technology, will support its scale-up and commercial adoption in India.

In a separate development aligned with the broader objective of advancing Bio-IBA adoption, Praj is currently establishing India’s first commercial Bio-IBA demonstration plant for a leading Oil Marketing Company (OMC). The project is being designed, engineered, supplied and erected by Praj based on Gevo’s licensed Bio-IBA technology. The demonstration plant is expected to play an important role in validating production, supply-chain and market-development pathways for future commercialization opportunities in India.

Bio-IBA presents a promising opportunity for reducing the carbon footprint of diesel across a wide range of applications, including: transportation, agriculture, mining, construction and industrial operations. Given India’s large diesel economy and abundant renewable feedstock resources, Bio-IBA has the potential to become an important component in the country’s transition towards lower-carbon fuels. According to Petroleum Planning & Analysis Cell (PPAC), India consumed approximately 94.7 million tonnes (29.7 billion US gallons) of high-speed diesel in FY2025-26.

Encouragingly, stakeholders across the value chain, including fuel producers, vehicle and equipment manufacturers, research institutions and end users, are actively working towards enabling Bio-IBA-based diesel blending in India. Multiple initiatives aimed at technology validation, application development, regulatory assessment and supply-chain preparedness are progressing in parallel, reflecting growing industry interest in bringing diesel blending solutions to commercial reality.

“This agreement marks an important milestone in our relationship with Praj and in the advancement of Bio-IBA in India,” said Gevo Chief Executive Officer Paul Bloom. “Gevo brings proven renewable isobutanol technology and commercialization experience, while Praj contributes deep expertise in engineering, deployment and market development. Together, we are creating a framework to unlock new opportunities for Bio-IBA, particularly in diesel applications, while supporting broader decarbonization objectives.”

“Our collaboration with Gevo has steadily evolved through technology development, application innovation and market-building efforts over the years,” said Dr. Pramod Chaudhari, Founder Chairman, Praj Industries. “This Development & Commercialization Agreement establishes a strong foundation for bringing Bio-IBA to the Indian market. We believe Bio-IBA has the potential to emerge as an important renewable fuel solution for the diesel economy, complementing India’s broader energy transition and sustainability goals.”

Beyond diesel applications, Bio-IBA also serves as a platform molecule for the production of Sustainable Aviation Fuel (SAF) and other renewable chemicals, further highlighting its versatility and expected long-term strategic importance within the emerging bioeconomy.

About Praj: 

Praj Industries Limited is a global biotechnology and engineering company driven by innovation, integration and delivery capabilities. Over the past four decades, Praj has been enabling the transition to a sustainable future through solutions across the Bioeconomy, Energy Transition and Industrial Infrastructure. With over 1,000 customer references in more than 100 countries across six continents, Praj has established itself as a trusted global technology and engineering partner.

Bio-Mobility^® and Bio-Prism^® are the cornerstones of Praj’s contribution to the global Bioeconomy. The Bio-Mobility^® platform offers technology solutions for the production of renewable transportation fuels, supporting sustainable decarbonization through a circular bioeconomy. The Bio-Prism^® portfolio comprises technologies for renewable chemicals and materials that advance sustainability while reimagining nature.

Praj Matrix, the Company’s state-of-the-art research and development centre, drives the development of next-generation technologies for clean energy, renewable fuels, chemicals and materials.

The Company’s wholly owned subsidiaries further strengthen its capabilities across high-growth sectors. Praj GenX delivers advanced manufacturing, modular process systems and critical process equipment for industries including oil & gas, advanced biofuels, sustainable aviation fuel (SAF), hydrogen, carbon capture and mission-critical digital infrastructure, including hyperscale data centers. Praj HiPurity Systems provides high-purity process systems and turnkey solutions for the pharmaceutical, biotechnology, healthcare and allied industries.

Praj’s diversified portfolio spans Bio-energy solutions, Critical Process Equipment & Modular Systems, High Purity Systems, Industrial Wastewater Treatment, Zero Liquid Discharge (ZLD) solutions, Breweries and emerging engineering solutions for global infrastructure markets. Guided by purpose-driven leadership and a commitment to sustainability, Praj continues to create value for customers, communities and stakeholders worldwide.

Praj Industries Limited is listed on the BSE Limited and the National Stock Exchange of India Limited (NSE).

About Gevo

Gevo is pioneering low-carbon solutions with cost-effective, drop-in fuels that contribute to energy security, abate carbon and strengthen rural communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including SAF, motor fuels, chemicals, and other materials. Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol plant with an adjacent carbon capture and storage (CCS) facility and Class VI carbon-storage well. Gevo also owns and operates one of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy.

For more information, please go to www.gevo.com.

Gevo Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including Gevo’s isobutanol technology, the interest in and commercial opportunities for isobutanol in the India market, Gevo’s business strategy and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

For media inquiries, please contact:

Priyanka Watane
Assistant General Manager, Corporate Communications
Praj Industries
Email: priyankawatane@praj.net
Phone: +91 20 6675 4000 / 22922001 Website: www.praj.net

Joan Cetera
Vice President, Communications
Gevo, Inc.
Email: jcetera@gevo.com
Web site: www.gevo.com

Presentation to highlight Nanjing Phase II ramp-up and lower unit production costs, an approximately US$96 million Indian order and AI data center validation progress

DALIAN, China, Sept. 16, 2026 (GLOBE NEWSWIRE) — CBAK Energy Technology Limited (NASDAQ: CBAT) (“CBAK Energy” or the “Company”), a leading China-based lithium-ion battery manufacturer and energy solutions provider, today announced that its Chief Financial Officer, Jiewei Li, will present at the October 2026 Emerging Growth Virtual Equity Conference, hosted by Noble Capital Markets, on October 1, 2026. The presentation will highlight the completed ramp-up of the Company’s Nanjing Phase II facility and the associated decline in unit production costs, growth in Model 32140 cell shipments, the approximately US$96 million Indian customer order, progress in customer validation of its full-tab 26650 lithium iron phosphate (“LFP”) cells for battery backup unit (“BBU”) and uninterruptible power supply (“UPS”) applications in AI data centers, and first-quarter 2026 revenue growth.

DATE: October 1, 2026
TIME: 9:30 – 10:00 a.m. ET

REGISTER HERE

Mr. Li will deliver a corporate presentation and participate in a live Q&A session. The conference will also offer scheduled one-on-one meetings with qualified investors. Investors are encouraged to register in advance and visit the conference website for the latest agenda, meeting availability and event updates.

Learn more about the event at https://nobleconference.com/virtual/

Recent Company Highlights

• Manufacturing Expansion and Lower Unit Costs: CBAK Energy completed the ramp-up of its Nanjing Phase II facility in August 2026. As previously disclosed, unit production costs have declined following completion of the ramp-up. Shipments of the Company’s Model 32140 cells reached approximately 32.55 million units during the first seven months of 2026, up 101.5% year over year and approximately 8.6% above full-year 2025 shipment volume. Daily production capacity at the Nanjing Phase II facility reached approximately 177,800 cells in July 2026, up 174.0% from January 2026.
• Approximately US$96 Million Indian Order: In August 2026, the Company secured a battery cell order from one of India’s leading two- and three-wheeler manufacturers, with an estimated value of approximately US$96 million, excluding applicable taxes. The Company expects to complete deliveries in 2027, and the order is expected to bring the designated manufacturing facility to full capacity utilization. The Company is also in advanced discussions with another prospective customer that ranks among India’s five largest two- and three-wheeler manufacturers regarding a potentially sizable order for the same cell model.
• AI Data Center Validation Advances to Module Level: The Company’s 26650 HP V2.0 and 26650 PFS2 V2.0 full-tab LFP cells, developed for BBU and UPS applications in AI data centers, continue to undergo customer testing and validation. Multiple prospective customers have advanced to module-level validation. Under specified internal test conditions, the cells recorded internal resistance below 3 mΩ and achieved maximum discharge power of approximately 260 W and 310 W, respectively.
• First-Quarter Revenue Growth: First-quarter 2026 unaudited net revenues increased 99.3% year over year to US$69.62 million, and net revenues from light electric vehicle applications increased 441.6% year over year to US$15.41 million.

About CBAK Energy

CBAK Energy Technology Limited (NASDAQ: CBAT) is a leading China-based high-tech company engaged in the development, manufacture and sale of high-power lithium-ion and sodium-ion batteries, as well as materials used in the manufacture of high-power lithium-ion batteries. The Company’s battery cell production, research and development, and sales operations are located in Nanjing, Dalian and Shangqiu. The Company also operates battery cell research and development centers in both Nanjing and Dalian. Its raw materials operations, including production, research and development, and sales, are headquartered in Shaoxing. The Company’s products and solutions serve electric vehicles, light electric vehicles, energy storage systems and other high-power applications. In January 2006, CBAK Energy became the first Chinese lithium battery manufacturer to be listed on the Nasdaq Stock Market.

About Noble Capital Markets

Established in 1984, Noble Capital Markets is an SEC- and FINRA-registered full-service investment bank and advisory firm serving public and private middle-market companies and investors. The firm provides investment banking, equity research, corporate access, and institutional sales and trading services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements regarding the Company’s expected participation in the Noble Capital Markets October 2026 Emerging Growth Virtual Equity Conference, its planned presentation and related investor meetings; the timing and fulfillment of the approximately US$96 million Indian customer order and its expected impact on production capacity utilization; the outcome, timing, volume, value and terms of the Company’s discussions with another prospective Indian customer and whether those discussions result in a definitive order; and customer testing, validation and qualification of the Company’s AI data center backup power products, potential customer demand for such products and whether testing and qualification result in commercial orders.

These forward-looking statements are based on the Company’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks include changes to the conference schedule, format or the Company’s participation; changes in customer demand, product adoption, order timing or order volumes; order modifications, delays or cancellations; production interruptions, shortages of raw materials, product quality issues, logistics disruptions or working capital constraints; the Company’s ability to fulfill the approximately US$96 million Indian customer order and translate it into production, shipments, revenue and customer payment; the possibility that the prospective Indian customer discussions do not result in a definitive order, or result in an order with a smaller volume or value, different terms or later timing than expected; the outcomes of customer testing, validation and qualification, whether products meet customer requirements and whether testing and qualification result in commercial orders; and other risks described in the Company’s reports filed with or furnished to the U.S. Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please visit: https://en.cbak.com.cn/
Email: marketing@cbak.com.cn
LinkedIn: https://www.linkedin.com/company/cbakenergy
X: https://x.com/CBAKEnergy
Stocktwits: https://stocktwits.com/CBAK_Energy
Investor Relations
Email: ir@cbak.com.cn
Website: https://ir.cbak.com.cn/

BURLINGTON, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) — Progress Software (Nasdaq: PRGS), a member of the Russell 2000 Index and an AI infrastructure software leader, today announced that it will release financial results for its fiscal third quarter of 2026 after the market close on Wednesday, September 30, 2026. Progress will host a conference call to review and discuss the results at 5:00 p.m. ET the same day. The company’s third quarter of fiscal year 2026 ended on August 31, 2026.

Conference Call Details
A live webcast of the call will be available using this link.

To access the conference call by phone, please use this link to retrieve dial-in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time.

An archived version of the conference call and supporting materials will be available on the Progress Investor Relations webpage after the live conference call.

About Progress Software
Progress Software (Nasdaq: PRGS) provides the context and control organizations need to reliably extract value from AI—context drawn from an organization’s data, content and workflows, and control over the security, governance and cost of their AI initiatives. Learn how hundreds of thousands of businesses, powering the work of tens of millions of professionals worldwide, realize value from trusted, enterprise-ready AI at www.progress.com.

Progress is a trademark or registered trademark of Progress Software Corporation and/or its subsidiaries or affiliates in the U.S. and other countries. Any other names contained herein may be trademarks of their respective owners.  

Investor Contact:		Press Contact:
Michael Micciche		Jeff Young
Progress Software		Progress Software
+1 781-850-8450		+1 781-280-4000
Investor-Relations@progress.com		PR@progress.com

Source: Progress Software Corporation

Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy

ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D., Medical Director of Pain and Spine Specialists, and Pain and Spine Specialists have joined Milestone Scientific as a development partner and member of the Company’s CompuFlo Advisor Program.

Pain and Spine Specialists is a leading multi-state interventional pain management organization with 22 locations across Maryland, Pennsylvania, Virginia and Florida. The organization provides comprehensive pain management services through a team of board-certified and fellowship-trained physicians and healthcare professionals focused on individualized patient care and advanced interventional treatment.

The practice has an extensive presence throughout Maryland and Pennsylvania, as well as locations in Virginia and Florida. This broad clinical footprint provides Milestone with an opportunity to collaborate with physicians and clinical teams across diverse practice environments and patient populations.

Importantly, the practice’s geographic footprint aligns with two strategically important Medicare Administrative Contractor regions for Milestone. Its substantial presence in Maryland and Pennsylvania falls within Medicare Jurisdiction L, administered by Novitas Solutions, while its Florida locations fall within Medicare Jurisdiction N, administered by First Coast Service Options.

The collaboration is designed to provide Milestone Scientific with direct, real-world feedback from physicians and clinical teams actively performing interventional pain procedures. As a development partner and member of the CompuFlo Advisor Program, Dr. Rao and his team will provide insights and recommendations regarding clinical workflows, product functionality, physician and staff experience, training, future applications and ongoing product development.

The relationship is also expected to contribute real-world clinical experience and physician engagement as Milestone continues its longer-term reimbursement strategy, including its journey toward establishing Category I CPT status for objective epidural confirmation.

Dr. Rao commented:

“I’m excited to serve as a development partner and join the CompuFlo Advisor Program. I’ve always believed in staying on the leading edge of technologies that simply make sense—innovations that can improve patient care, enhance physician confidence, and ultimately have the potential to become the standard of care.”
— Sudhir Rao, M.D., Medical Director, Pain and Spine Specialists

Eric Hines, Chief Executive Officer of Milestone Scientific, commented:
“Having customers who are in the trenches every day using our technology and treating patients is invaluable. The best product development doesn’t happen in isolation. It comes from listening to physicians and clinical teams, understanding how technology performs within actual clinical workflows, and incorporating their insights and recommendations into what we develop next. Dr. Rao and the Pain and Spine Specialists team bring exactly that kind of real-world experience to our CompuFlo Advisor Program.”

Hines continued:
“Epidural procedures take place within a critical and highly confined anatomical space. Physician skill, experience and tactile judgment are extremely important, but we believe technology can provide physicians with additional objective information rather than relying on tactile judgment alone. CompuFlo’s ability to provide objective, real-time pressure information to assist in confirming epidural needle placement simply makes sense to us from a patient-care perspective. Our goal is to work alongside leading physicians such as Dr. Rao to continue refining the technology, integrating it efficiently into clinical workflows and building the clinical experience necessary for objective epidural confirmation to ultimately become a standard of care.”

Hines added:
“This collaboration is also an important part of our broader journey toward Category I CPT status. Working with high-volume, multi-location practices such as Pain and Spine Specialists can help us expand real-world clinical utilization, deepen physician engagement and generate valuable insights into how CompuFlo integrates into everyday clinical practice. We believe these relationships can contribute to the clinical experience and supporting evidence needed as we pursue our longer-term reimbursement objectives.”

About CompuFlo®
Milestone Scientific’s CompuFlo technology utilizes the Company’s proprietary Dynamic Pressure Sensing® technology to provide objective, real-time pressure information during needle placement.
The technology is designed to complement physician skill and clinical judgment by providing an additional source of objective information during procedures in which accurate needle placement is critical.

The CompuFlo Advisor Program establishes structured collaborations between Milestone Scientific and experienced practicing clinicians. Participating physicians and organizations provide real-world feedback regarding product performance, clinical workflow, training, education, future applications and product development, helping Milestone align its innovation efforts with the needs of physicians and patients.

About Pain and Spine Specialists
Pain and Spine Specialists is a multi-state comprehensive pain management organization with 22 locations across Maryland, Pennsylvania, Virginia and Florida. Its team of board-certified and fellowship-trained physicians and healthcare professionals provides individualized treatment for patients suffering from chronic and acute pain conditions using comprehensive and interventional approaches designed to improve quality of life and functionality.

Sudhir Rao, M.D., serves as Medical Director of Pain and Spine Specialists.

To learn more, please visit: https://painandspinespecialists.com/

About Milestone Scientific Inc.
Milestone Scientific Inc. (NYSE American: MLSS) develops and commercializes innovative computerized drug delivery technologies designed to improve the precision, consistency and patient experience associated with injections and related procedures. The Company’s proprietary Dynamic Pressure Sensing® technology provides healthcare professionals with objective, real-time pressure information that can assist in identifying tissue types and confirming needle placement. To learn more, view the MLSS brand video or visit milestonescientific.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable federal securities laws, including statements regarding the potential benefits, adoption, development, clinical use, reimbursement, commercialization, future applications, potential Category I CPT status and potential standard-of-care status of the Company’s technologies. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Additional information concerning these and other risks is contained in Milestone Scientific’s filings with the U.S. Securities and Exchange Commission. Milestone Scientific undertakes no obligation to update forward-looking statements except as required by law.

Contact:

HAYDEN IR:
James Carbonara
(646)-755-7412
james@haydenir.com

Brett Maas
(646) 536-7331
brett@haydenir.com

Learning Time International Schools agreement builds on Saudi pilots, combining AI‑assisted Chinese learning with individual practice beyond the classroom

RIYADH, Saudi Arabia, Sept. 16, 2026 (GLOBE NEWSWIRE) — Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun” or the “Company”) announced that Link Door Smart Company (“Link Door”), its Saudi‑based strategic associate, has signed a procurement and service agreement with Learning Time International Schools for the HanLink Chinese Learning Platform. The agreement adds a paid school contract to HanLink’s development in Saudi Arabia, where the platform combines classroom learning tools with an AI “Han” teacher that supports individual language practice beyond scheduled lessons.

The agreement has a total value of SAR100,000, excluding VAT, and covers a non‑exclusive, non‑transferable platform license for the 2026/2027 academic year. Link Door is responsible for platform deployment and account activation, basic operational training for teachers and administrators, and technical support, maintenance and system updates during the contract term.

From Saudi Pilot to School Contract

HanLink’s Saudi development began with classroom experience. In May 2025, Ruanyun announced the platform’s launch and a four‑week pilot at Education & Skills International School in Riyadh. The pilot introduced HanLink into a school setting, providing an early opportunity to observe how students and teachers used AI‑assisted Chinese language learning tools.

The project then broadened into institutional cooperation. In July 2025, Ruanyun announced a strategic cooperation agreement with the Confucius Institute at Prince Sultan University, with plans encompassing Chinese language instruction, localized learning materials and educator development. That agreement contemplated combining HanLink with teaching resources and institutional support tailored to Saudi learners.

In May 2026, Ruanyun announced Link Door’s procurement and service agreement with Alfyaseh Trading Est., taking a further commercial step through a Saudi customer‑facing partner. The Learning Time International Schools agreement now carries that progression into a contract covering platform access and support for a school academic year.

From Classroom Learning to Individual AI Practice

HanLink’s AI “Han” teacher is designed to provide round‑the‑clock language practice, questions and answers, and learning consultation in Arabic, English and Chinese. Students can continue practising beyond scheduled lessons through pronunciation feedback, Chinese character exercises and conversational activities. The Company believes that access to individual AI interaction can support a more learner‑centred approach, giving students additional opportunities to practise at their own pace.

The Learning Time International Schools agreement combines platform access with account setup, basic training for teachers and administrators, and continuing technical support. It follows HanLink’s earlier Saudi pilot work and local commercialization arrangements, bringing those capabilities into a paid contract for the 2026/2027 academic year. Deployment is contractually due within five business days after Link Door receives the initial payment; the agreement provides for a term of one academic year from official activation.

“Our aim is to make Chinese language practice available whenever a student is ready to learn. A scheduled lesson can introduce a concept, while individual interaction with AI Han gives students opportunities to ask questions, practise pronunciation and revisit material afterwards. We believe this connection between classroom learning and continued individual practice is central to HanLink’s value for schools and learners as we develop its international business.”

Maggie Fu, Chief Executive Officer, Ruanyun Edai Technology Inc.

Related Party Disclosure

Link Door is a separately owned Saudi company. As previously disclosed, Link Door is 75% owned by Maggie Fu, the Company’s Chief Executive Officer, and 25% owned by Cong Zhao, the Company’s Chief Technology Officer. The procurement and service agreement described in this release is between Link Door and Learning Time International Schools; Ruanyun is not a signatory to that agreement. The Company’s previously disclosed HanLink licensing arrangement with Link Door is through Jiangxi Ruanyun Technology Co., Ltd., its consolidated variable interest entity in China.

Link Door’s status as a strategic associate does not, by itself, mean that it is a subsidiary of Ruanyun or consolidated in Ruanyun’s financial statements. The SAR100,000 contract value is not equivalent to Ruanyun revenue, backlog or cash receipts. Any amounts attributable to Ruanyun’s operating entities, and the timing of any revenue recognition, depend on the applicable licensing and service arrangements, performance obligations, collectability and relevant accounting requirements.

About HanLink

HanLink is an AI‑assisted Chinese language learning platform developed within the Ruanyun ecosystem. Its AI “Han” teacher provides language practice, questions and answers, and learning consultation. The platform also includes pronunciation and Chinese character practice, conversational activities, teacher tools and learning analytics, supporting learning during and beyond scheduled lessons.

About Ruanyun Edai Technology Inc.

Ruanyun Edai Technology Inc. is an AI‑driven education technology company focused on intelligent content recognition, automated assessment and next‑generation learning systems. The Company has historically developed and provided AI‑enabled teaching, learning and assessment solutions, including smart homework, smart examination and digital education services. Subject to shareholder approval and applicable corporate and regulatory processes, the Company plans to transition toward the Formind Group identity as part of its broader strategy to expand its AI education, language learning, institutional education support and global technology initiatives.

Forward-Looking Statements

This press release contains forward‑looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and applicable securities laws. All statements other than statements of historical fact are forward‑looking statements. Forward‑looking statements may be identified by words such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “goal,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” and similar expressions.

These statements include, among others, statements regarding the significance and commercial impact of the agreement; the deployment, activation, operation, training, maintenance and support of HanLink; payment and any revenue contribution under applicable arrangements; the development, adoption and commercialization of HanLink in Saudi Arabia; the anticipated benefits of AI teaching capabilities, individual practice, learner-centred education, institutional cooperation and local delivery and support; and the Company’s international education strategy and planned transition toward the Formind Group identity.

Forward‑looking statements are based on current expectations, estimates, assumptions and projections and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, among others, the ability of Link Door and the relevant Ruanyun operating entities to perform their respective obligations; deploy, activate and support the platform; secure customer cooperation and acceptance; maintain applicable licensing, channel and service arrangements; collect payments and satisfy revenue recognition requirements; manage related‑party arrangements and conflicts of interest; manage AI response accuracy, instructional quality, age-appropriate use and learner engagement; protect intellectual property and user data; comply with education, data protection, cybersecurity, localization, tax and other regulatory requirements in Saudi Arabia and other relevant jurisdictions; and secure the personnel, infrastructure, financing and approvals needed to execute the Company’s international strategy and planned corporate transition.

The agreement does not guarantee additional customer contracts, broader institutional adoption, successful market expansion or any particular operating or financial result for Ruanyun. The Company is not providing financial guidance in this release.

Forward‑looking statements speak only as of the date of this press release. Additional risks are described in the Company’s reports filed with or furnished to the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20‑F. Readers should not place undue reliance on these statements. The Company undertakes no obligation to update any forward‑looking statement except as required by law.

Investor Relations and Corporate Communications
FSR Capital, a FSR Group Company
Email: ir@fsr.group